The NAD ratio redox paradox: why does too much reductive power cause oxidative stress?
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The reductive power provided by nicotinamide adenine dinucleotides is invaluable for several cellular processes. It drives metabolic reactions, enzymatic activity, regulates genetic expression and allows for the maintenance of a normal cell redox status. Therefore, the balance between the oxidized (NAD(+)) and the reduced (NADH) forms is critical for the cell's proper function and ultimately, for its survival. Being intimately associated with the cells' metabolism, it is expected that alterations to the NAD(+)/NADH ratio are to be found in situations of metabolic diseases, as is the case of diabetes. NAD(+) is a necessary cofactor for several enzymes' activity, many of which are related to metabolism. Therefore, a decrease in the NAD(+)/NADH ratio causes these enzymes to decrease in activity (reductive stress), resulting in an altered metabolic situation that might be the first insult toward several pathologies, such as diabetes. Here, we review the importance of nicotinamide adenine dinucleotides in the liver cell and its fluctuations in a state of type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α
Nemoto, S., Fergusson, M. M., & Finkel, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501485200 · Cited by 1,047
Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007 · cited 1×
“…start to diverge more actively to parallel pathways, as the sorbitol pathway, advance glycation end product pathway, hexosamine pathway and the protein kinase C pathway, which are known for their influence in oxidative unbalance and ROS generation (Hammes et al., 2003; Rolo & Palmeira, 2006).”
BackgroundSelf-citationAMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903 · cited 1×
“Therefore, it appears that AMPK and SirT1 share a common goal and, through their interactions and activities, are part of the energetic modulation of the cell (Ruderman et al., 2010).”
BackgroundHammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785 · cited 13×
“This reduction seems to take place early due to increased oxidative damage caused by decreased respiratory rates and mitochondrial replication (increased hyperpolarization of the mitochondrial membrane leads to increased ROS generation, which is augmented by decreased mitochondrial numbers) (Palmeira et al., 2007), bu…”
BackgroundInfluentialFeige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719 · cited 1×
“Also, the relationship between NADþ, diabetes, SirT1 and PGC-1a has been approached in several reports (Chau et al., 2010; Chaudhary & Pfluger, 2009; Feige et al., 2008; Purushotham et al., 2009; Rodgers et al., 2005); however, the need for further clarification of this critical step of metabolic…”
BackgroundCalorie restriction induces mitochondrial biogenesis and bioenergetic efficiency
López-Lluch, G., Hunt, N., Jones, B., Zhu, M., Jamieson, H., Hilmer, S., Cascajo, M. V., Allard, J., Ingram, D. K., Navas, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510452103 · Cited by 699
Gembal, M., Gilon, P., & Henquin, J. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115714 · Cited by 494 · cited 9×
“In turn, the diminished need for substrates and increase in ATP is accompanied by an increase in NADH, in both the cytosol and the mitochondria.”
BackgroundInfluentialBefroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., de Graaf, R. A., Rothman, D. L., & Shulman, G. I. (2007) · Diabetes · doi:10.2337/db06-0783 · Cited by 453 · cited 2×
“increase in mitochondrial substrate oxidation and others reporting a decrease (Befroy et al., 2007; López-Lluch et al., 2006; Sinclair, 2005).”
BackgroundEffects of exercise on mitochondrial content and function in aging human skeletal muscle
Menshikova, E. V., Ritov, V. B., Fairfull, L., Ferrell, R. E., Kelley, D. E., & Goodpaster, B. H. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.6.534 · Cited by 398 · cited 1×
“Several works have reported a decrease in mitochondrial content and/or function in hyperglycemia and diabetes (Laye et al., 2009; Menshikova et al., 2006; Palmeira et al., 2007; Rabøl et al., 2009; Ukropcova et al., 2007; Wong et al., 2009).”
BackgroundEnergy-sensing and signaling by AMP-activated protein kinase in skeletal muscle
Winder, W. W. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1017 · Cited by 375 · cited 1×
“This activity is not surprising since, as its name implies, it acts as a metabolic and energetic sensor (Hardie & Carling, 1997; Winder, 2001), regulating the expression of several key proteins in processes such as lipid and glucose management, exercise response, the process of aging and endocrine…”
BackgroundBoden, G. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-39781 · Cited by 348 · cited 2×
“In fact, whether it is glucose, free fatty acids (Boden, 2003), triglycerides (TG) (Frohlich & Steiner, 2000), lactate (Kelley & Mandarino, 1990), ketone bodies (Avogaro et al., 1996) or amino acids (Vannini et al., 1982), there is a permanent increase in the availability of metabolic substrates.”
BackgroundRole of insulin-induced reactive oxygen species in the insulin signaling pathway
Goldstein, B. J., Mahadev, K., Wu, X., Zhu, L., & Motoshima, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1021 · Cited by 238
Kelley, D. E., & Mandarino, L. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114935 · Cited by 210 · cited 1×
“In fact, whether it is glucose, free fatty acids (Boden, 2003), triglycerides (TG) (Frohlich & Steiner, 2000), lactate (Kelley & Mandarino, 1990), ketone bodies (Avogaro et al., 1996) or amino acids (Vannini et al., 1982), there is a permanent increase in the availability of metabolic substrates.”
BackgroundEffect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
Rabøl, R., Højberg, P. M. V., Almdal, T., Boushel, R., Haugaard, S. B., Madsbad, S., & Dela, F. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1475 · Cited by 66 · cited 1×
“Several works have reported a decrease in mitochondrial content and/or function in hyperglycemia and diabetes (Laye et al., 2009; Menshikova et al., 2006; Palmeira et al., 2007; Rabøl et al., 2009; Ukropcova et al., 2007; Wong et al., 2009).”
BackgroundOliveira, R. L. G. S., Ueno, M., de Souza, C. T., Pereira-da-Silva, M., Gasparetti, A. L., Bezzera, R. M. N., Alberici, L. C., Vercesi, A. E., Saad, M. J. A., & Velloso, L. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00103.2004 · Cited by 65
Cited by
Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L.-J. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 397
Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
Yan, L.-J., Wu, J., Jin, Z., & Zheng, H. (2016) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s106087 · Cited by 198
Precision Redox: The Key for Antioxidant Pharmacology
Meng, J., Lv, Z., Zhang, Y., Wang, Y., Qiao, X., Sun, C., Chen, Y., Guo, M., Han, W., Ye, A., et al. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8212 · Cited by 122
“For example, in HeLa cells, H2O2 treatment significantly increases the fluorescence value of NucHyPerRed (nuclear H2O2-sensitive probe) but has no effect on the ratio of NADH/NAD+ in the nucleus (116).”
BackgroundInfluentialvan der Kooij, M. A., Jene, T., Treccani, G., Miederer, I., Hasch, A., Voelxen, N., Walenta, S., & Müller, M. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804412115 · Cited by 92
CD38 promotes angiotensin II‐induced cardiac hypertrophy
Guan, X., Hong, X., Zhao, N., Liu, X., Xiao, Y., Chen, T., Deng, L., Wang, X., Wang, J., Ji, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13076 · Cited by 90
“Oxidative stress is always associated with NAD depletion [10] or NAD-consuming enzymes activation.”
Background
Metadata
- Authors
- Teodoro, J. S., Rolo, A. P., & Palmeira, C. M.
- Venue
- Toxicology Mechanisms and Methods
- Publisher
- Informa UK Limited
- Published
- 2013-01-28
- Volume
- 23
- Issue
- 5
- Pages
- 297-302
- ISSN
- 1537-6516 (ISSN-L)
- 1537-6524
- OpenAlex
- W2087076407
- Cited by
- 75
- References
- 19
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.